Literature DB >> 22041607

Mucositis, conjunctivitis but no rash - the "Atypical Stevens - Johnson syndrome".

D C R McGouran1, T Petterson, J M McLaren, M P Wolbinski.   

Abstract

The Stevens-Johnson syndrome (SJS) classically involves a rash, conjunctivitis and mucositis. We describe the case of a young adult male with isolated mucositis and conjunctivitis . Previous rare reports of severe SJS like syndromes without a rash are confined to children, usually with mycoplasma pnemoniae infection.(1) Terminology for this syndrome includes - "Stevens-Johnson Syndrome without skin lesions", or "Atypical Stevens - Johnson Syndrome".(2) This case highlights the importance of maintaining an open mind when a "full house" of clinical features is absent. It also illustrates the use of a rapid electronic literature review as a clinical tool. The importance of updating records when a drug has been cleared of causing harm is highlighted.

Entities:  

Mesh:

Year:  2011        PMID: 22041607

Source DB:  PubMed          Journal:  Acute Med        ISSN: 1747-4884


  3 in total

1.  Outbreak of Mycoplasma pneumoniae-Associated Stevens-Johnson Syndrome.

Authors:  Daniel Olson; Louise K Francois Watkins; Alicia Demirjian; Xia Lin; Christine C Robinson; Kristin Pretty; Alvaro J Benitez; Jonas M Winchell; Maureen H Diaz; Lisa A Miller; Teresa A Foo; Melanie D Mason; Ursula L Lauper; Oren Kupfer; Jeffrey Kennedy; Mary P Glodé; Preeta K Kutty; Samuel R Dominguez
Journal:  Pediatrics       Date:  2015-08       Impact factor: 7.124

2.  Letter to the Editor: Bilateral Subconjunctival Hemorrhage in a 3-Year-Old Girl with Mycoplasma Pneumonia.

Authors:  Tatsuya Mimura; Hidetaka Noma; Satoru Yamagami
Journal:  Open Ophthalmol J       Date:  2017-11-21

3.  A cute bilateral conjunctivitis with nasooral involvement: A rare manifestation of tuberculosis.

Authors:  Suresh Palanisamy; Anita D Mathews; Somasheila I Murthy
Journal:  Indian J Ophthalmol       Date:  2020-04       Impact factor: 1.848

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.